Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 12, 2020 at 08:20 pm IST
Share
Sunmax Biotechnology Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 193.000 million compared to TWD 189.643 million a year ago. Operating income was TWD 21.254 million compared to TWD 83.170 million a year ago. Net income was TWD 18.903 million compared to TWD 58.801 million a year ago. Basic earnings per share was TWD 0.35 compared to TWD 1.08 a year ago. For the nine months, sales was TWD 560.018 million compared to TWD 440.214 million a year ago. Operating income was TWD 209.242 million compared to TWD 152.632 million a year ago. Net income was TWD 136.183 million compared to TWD 114.654 million a year ago. Basic earnings per share was TWD 2.5 compared to TWD 2.11 a year ago. Diluted earnings per share was TWD 2.5 compared to TWD 2.1 a year ago.
SunMax Biotechnology Co., Ltd. is a Taiwan-based company principally engaged in research, development, production and distribution of collagen implants and related products. The Company's major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, as well as medical collagen application equipment. Its products are applied in medical and beauty care industrials. The Company distributes its products principally in Taiwan, Mainland China and other regions.
SUNMAX BIOTECHNOLOGY CO., LTD. 